WebDisclosure WebDisclosure
Basculer en Français
10767 Companies
231815 Keywords
160268 Articles
123344 Press releases
Headlines Articles Press releases Lucera GmbH Remove
  1. Home
  2. Companies
  3. Lucera GmbH
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/02/2026 at 08:05, 1 month 23 days ago

    Lucera Launches to Revolutionize Drug Development with Decision Intelligence

    Drug Development Decision Intelligence TechBio Launch Dataome® Technology Biopharmaceutical R&D
  • BRIEF

    published on 06/02/2026 at 08:05, 1 month 23 days ago

    Lucera lance une solution révolutionnaire pour le développement de médicaments grâce à l'intelligence décisionnelle.

    Intelligence Décisionnelle Développement De Médicaments Recherche Et Développement Biopharmaceutiques Lancement De TechBio Technologie Dataome®
  • PRESS RELEASE

    published on 06/02/2026 at 08:00, 1 month 23 days ago

    Launch of TechBio firm, Lucera, brings decision intelligence to drug development, making it more predictable, more evidence-grounded, and more efficient

    Lucera GmbH launches TechBio firm specializing in decision intelligence for drug development, leveraging Dataome® technology for more efficient processes
    Drug Development Decision Intelligence Lucera GmbH TechBio Dataome®
    Logo of Lucera GmbH
Accesswire
  • Published on 07/25/2026 at 00:35, 17 hours 9 minutes ago

    Pathfinder Ventures Inc. Provides Corporate Update

  • Published on 07/24/2026 at 23:00, 18 hours 44 minutes ago

    NV Gold Announces Closing of Non-Brokered Private Placement

  • Published on 07/24/2026 at 22:15, 19 hours 29 minutes ago

    Gold Terra Announces Closing of First Tranche of C$10.8M LIFE Offering With Strong Participation From Strategic Shareholder David Harquail

  • Published on 07/24/2026 at 22:05, 19 hours 39 minutes ago

    Findev Inc. Announces CCAA Proceedings Involving 1682 Victoria Park Avenue Inc. and Related Party Subordination Arrangement

  • Published on 07/24/2026 at 20:00, 21 hours 44 minutes ago

    Unusual Machines to Announce Second Quarter 2026 Financial Results and Provide Corporate Update

View all ACCESSWIRE
EQS Group
  • Published on 07/24/2026 at 19:06, 22 hours 37 minutes ago

    End of Stabilisation Notice

  • Published on 07/24/2026 at 19:04, 22 hours 39 minutes ago

    Stabilisation Notice

  • Published on 07/24/2026 at 18:44, 22 hours 59 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 07/24/2026 at 18:15, 23 hours 29 minutes ago

    EUROPLASMA: Tirage des deux premières tranches du financement obligataire en vue de l’émission de 400 obligations convertibles en actions nouvelles pour un montant nominal de 2 M€

  • Published on 07/24/2026 at 17:50, 23 hours 53 minutes ago

    Fuller, Smith & Turner PLC: Director / PDMR Shareholding

View all EQS
Les Echos
  • Published on 07/25/2026 at 07:00, 10 hours 44 minutes ago

    DLSI - Chiffre d'affaires 1er semestre 2026

  • Published on 07/24/2026 at 18:50, 22 hours 53 minutes ago

    Disclosure of transactions in own shares from July 20 to July 24, 2026

  • Published on 07/24/2026 at 18:50, 22 hours 53 minutes ago

    Déclaration hebdomadaire d'opérations effectuées du 20 au 24 juillet 2026

  • Published on 07/24/2026 at 18:23, 23 hours 20 minutes ago

    Communiqué relatif au dépôt d'offre publique de retrait visant les actions Bourrelier Group

  • Published on 07/24/2026 at 18:11, 23 hours 32 minutes ago

    H1 2026 liquidity contract statement for TF1

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy